Common Contracts
1 similar Study Agreement contracts
CLINICAL STUDY AGREEMENT PROTOCOL: D5780C00007 SITE: 2003641XXXINSTITUTION: FAKULTNI NEMOCNICE USVATE ANNY V BRNE MEDIMMUNE, LLC 03-AUGUST-2018VERSION: VERSION#1 COUNTRY: CZECH REPUBLIC SMLOUVA O KLINICKÉ STUDII PROTOKOL: D5780C00007 PRACOVIŠTĚ:...Study Agreement • August 29th, 2018
CLINICAL STUDY AGREEMENTThis clinical study agreement (“Agreement”), is effective as of the day of publication of the fully executed Agreement in accordance with Clause 10.8 hereto (“Effective Date”), is entered into by and among Medpace Clinical Research, LLC, with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227 ("Medpace”), represented by XXX Clinical Trial Manager; andFakultni nemocnice u sv. Anny, with its principal office and place of business at Pekarska 53, 656 91 Brno, Czech Republic ("Institution”), represented by XXX, Director; and XXX with his principal residential address at XXX, date of birth XX.XX.XXX (“Principal Investigator”).Medpace, Institution, and Principal Investigator are sometimes collectively referred to herein as parties (the “Parties”). WHEREAS, MEDIMMUNE, LLC (“Sponsor”) issponsoring a clinical study on the compound MEDI6012 (the “Study Drug”), in accordance with Protocol No. D5780C00007 titled “A Randomized, Placebo-con
